The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]-3-[6-(4-ethylpiperazin-1-yl)pyridin-3-yl]-Nmethyl-1H-pyrazolo[3,4-d]pyrimidin-6-amine ID: ALA4217649
PubChem CID: 145974023
Max Phase: Preclinical
Molecular Formula: C27H31N11
Molecular Weight: 509.62
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCN1CCN(c2ccc(-c3nn(Cc4cn(Cc5ccccc5)nn4)c4nc(NC)ncc34)cn2)CC1
Standard InChI: InChI=1S/C27H31N11/c1-3-35-11-13-36(14-12-35)24-10-9-21(15-29-24)25-23-16-30-27(28-2)31-26(23)38(33-25)19-22-18-37(34-32-22)17-20-7-5-4-6-8-20/h4-10,15-16,18H,3,11-14,17,19H2,1-2H3,(H,28,30,31)
Standard InChI Key: PAZDHXLZWBCXCX-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
33.3425 -6.0340 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3413 -6.8535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0494 -7.2625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.0476 -5.6251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7562 -6.0304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7610 -6.8490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5410 -7.0974 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.0184 -6.4323 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.5333 -5.7729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7817 -4.9979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5814 -4.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8294 -4.0466 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.2788 -3.4416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4769 -3.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2326 -4.3972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5305 -2.6659 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.3299 -2.4920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5777 -1.7170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0294 -1.1105 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.2299 -1.2845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9788 -2.0648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7981 -7.8731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2548 -8.4836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4414 -8.4053 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.1134 -9.1537 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.7239 -9.6970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.4291 -9.2842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6333 -7.2615 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.9259 -6.8524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6432 -10.5102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8987 -10.8470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2370 -10.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4930 -10.7028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4119 -11.5169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0808 -11.9936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8221 -11.6549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2792 -0.3325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0780 -0.1598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
9 10 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
13 16 1 0
7 22 1 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 1 0
27 23 2 0
2 28 1 0
28 29 1 0
26 30 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 31 1 0
19 37 1 0
37 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 509.62Molecular Weight (Monoisotopic): 509.2764AlogP: 2.76#Rotatable Bonds: 8Polar Surface Area: 105.71Molecular Species: NEUTRALHBA: 11HBD: 1#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 7.71CX LogP: 3.31CX LogD: 2.83Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.34Np Likeness Score: -2.16
References 1. Myers SH, Temps C, Houston DR, Brunton VG, Unciti-Broceta A.. (2018) Development of Potent Inhibitors of Receptor Tyrosine Kinases by Ligand-Based Drug Design and Target-Biased Phenotypic Screening., 61 (5): [PMID:29466002 ] [10.1021/acs.jmedchem.7b01605 ]